Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Differentially expressed gene networks, biomarkers, long noncoding RNAs, and shared responses with cocaine identified in the midbrains of human opioid abusers.

Saad MH, Rumschlag M, Guerra MH, Savonen CL, Jaster AM, Olson PD, Alazizi A, Luca F, Pique-Regi R, Schmidt CJ, Bannon MJ.

Sci Rep. 2019 Feb 7;9(1):1534. doi: 10.1038/s41598-018-38209-8.

2.

Opioid Deaths: Trends, Biomarkers, and Potential Drug Interactions Revealed by Decision Tree Analyses.

Saad MH, Savonen CL, Rumschlag M, Todi SV, Schmidt CJ, Bannon MJ.

Front Neurosci. 2018 Oct 23;12:728. doi: 10.3389/fnins.2018.00728. eCollection 2018.

3.

Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.

Miller ML, Ren Y, Szutorisz H, Warren NA, Tessereau C, Egervari G, Mlodnicka A, Kapoor M, Chaarani B, Morris CV, Schumann G, Garavan H, Goate AM, Bannon MJ; IMAGEN Consortium, Halperin JM, Hurd YL.

Mol Psychiatry. 2018 May;23(5):1328-1335. doi: 10.1038/mp.2017.80. Epub 2017 Apr 25.

4.

Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system.

Espadas-Alvarez AJ, Bannon MJ, Orozco-Barrios CE, Escobedo-Sanchez L, Ayala-Davila J, Reyes-Corona D, Soto-Rodriguez G, Escamilla-Rivera V, De Vizcaya-Ruiz A, Eugenia Gutierrez-Castillo M, Padilla-Viveros A, Martinez-Fong D.

Nanomedicine. 2017 May;13(4):1363-1375. doi: 10.1016/j.nano.2017.02.006. Epub 2017 Feb 17.

PMID:
28219741
5.

Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers.

Bannon MJ, Savonen CL, Jia H, Dachet F, Halter SD, Schmidt CJ, Lipovich L, Kapatos G.

J Neurochem. 2015 Oct;135(1):50-9. doi: 10.1111/jnc.13255. Epub 2015 Sep 1.

6.

Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.

Hernandez-Chan NG, Bannon MJ, Orozco-Barrios CE, Escobedo L, Zamudio S, De la Cruz F, Gongora-Alfaro JL, Armendáriz-Borunda J, Reyes-Corona D, Espadas-Alvarez AJ, Flores-Martínez YM, Ayala-Davila J, Hernandez-Gutierrez ME, Pavón L, García-Villegas R, Nadella R, Martinez-Fong D.

J Biomed Sci. 2015 Jul 22;22:59. doi: 10.1186/s12929-015-0166-7.

7.

The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease.

Razgado-Hernandez LF, Espadas-Alvarez AJ, Reyna-Velazquez P, Sierra-Sanchez A, Anaya-Martinez V, Jimenez-Estrada I, Bannon MJ, Martinez-Fong D, Aceves-Ruiz J.

PLoS One. 2015 Feb 18;10(2):e0117391. doi: 10.1371/journal.pone.0117391. eCollection 2015.

8.

Investigating the potential influence of cause of death and cocaine levels on the differential expression of genes associated with cocaine abuse.

Bannon MJ, Savonen CL, Hartley ZJ, Johnson MM, Schmidt CJ.

PLoS One. 2015 Feb 6;10(2):e0117580. doi: 10.1371/journal.pone.0117580. eCollection 2015.

9.

A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype.

Bannon MJ, Johnson MM, Michelhaugh SK, Hartley ZJ, Halter SD, David JA, Kapatos G, Schmidt CJ.

Neuropsychopharmacology. 2014 Aug;39(9):2191-9. doi: 10.1038/npp.2014.70. Epub 2014 Mar 19.

10.

Authors' response.

Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ.

J Forensic Sci. 2013 Mar;58(2):562. doi: 10.1111/1556-4029.12080. No abstract available.

11.

Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels.

Jacobs MM, Ökvist A, Horvath M, Keller E, Bannon MJ, Morgello S, Hurd YL.

Mol Psychiatry. 2013 Nov;18(11):1205-10. doi: 10.1038/mp.2012.140. Epub 2012 Oct 9.

12.

Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium.

Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ.

J Forensic Sci. 2012 Nov;57(6):1519-23. doi: 10.1111/j.1556-4029.2012.02212.x. Epub 2012 Jul 16.

13.

NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Martinez-Fong D, Bannon MJ, Trudeau LE, Gonzalez-Barrios JA, Arango-Rodriguez ML, Hernandez-Chan NG, Reyes-Corona D, Armendáriz-Borunda J, Navarro-Quiroga I.

Nanomedicine. 2012 Oct;8(7):1052-69. doi: 10.1016/j.nano.2012.02.009. Epub 2012 Mar 7. Review.

14.

The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes.

Johnson MM, Michelhaugh SK, Bouhamdan M, Schmidt CJ, Bannon MJ.

Front Neurosci. 2011 Dec 20;5:135. doi: 10.3389/fnins.2011.00135. eCollection 2011.

15.

Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.

Zhou Y, Michelhaugh SK, Schmidt CJ, Liu JS, Bannon MJ, Lin Z.

Addict Biol. 2014 Jan;19(1):122-31. doi: 10.1111/j.1369-1600.2011.00391.x. Epub 2011 Oct 26.

16.

Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers.

Michelhaugh SK, Lipovich L, Blythe J, Jia H, Kapatos G, Bannon MJ.

J Neurochem. 2011 Feb;116(3):459-66. doi: 10.1111/j.1471-4159.2010.07126.x. Epub 2010 Dec 22.

17.

Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers.

Okvist A, Fagergren P, Whittard J, Garcia-Osta A, Drakenberg K, Horvath MC, Schmidt CJ, Keller E, Bannon MJ, Hurd YL.

Biol Psychiatry. 2011 Feb 1;69(3):245-52. doi: 10.1016/j.biopsych.2010.09.037. Epub 2010 Dec 3.

18.

Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Gyawali S, Subaran R, Weissman MM, Hershkowitz D, McKenna MC, Talati A, Fyer AJ, Wickramaratne P, Adams PB, Hodge SE, Schmidt CJ, Bannon MJ, Glatt CE.

Biol Psychiatry. 2010 Feb 15;67(4):331-8. doi: 10.1016/j.biopsych.2009.10.015. Epub 2009 Dec 6.

19.

Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Kristiansen LV, Bannon MJ, Meador-Woodruff JH.

Neurochem Res. 2009 Jan;34(1):46-54. doi: 10.1007/s11064-008-9655-3. Epub 2008 Mar 21.

20.

D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures.

Sin M, Michelhaugh SK, Bannon MJ.

Neuroreport. 2008 Jan 22;19(2):187-91. doi: 10.1097/WNR.0b013e3282f35595.

PMID:
18185106
21.
22.

Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats.

Gonzalez-Barrios JA, Lindahl M, Bannon MJ, Anaya-Martínez V, Flores G, Navarro-Quiroga I, Trudeau LE, Aceves J, Martinez-Arguelles DB, Garcia-Villegas R, Jiménez I, Segovia J, Martinez-Fong D.

Mol Ther. 2006 Dec;14(6):857-65. Epub 2006 Oct 2.

23.

Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection.

Arango-Rodriguez ML, Navarro-Quiroga I, Gonzalez-Barrios JA, Martinez-Arguelles DB, Bannon MJ, Kouri J, Forgez P, Rostene W, Garcia-Villegas R, Jimenez I, Martinez-Fong D.

Biochim Biophys Acta. 2006 Jul;1760(7):1009-20. Epub 2006 Apr 3.

PMID:
16730907
24.

Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse.

Albertson DN, Schmidt CJ, Kapatos G, Bannon MJ.

Neuropsychopharmacology. 2006 Oct;31(10):2304-12. Epub 2006 May 3.

25.

Improving child protection: a systematic review of training and procedural interventions.

Carter YH, Bannon MJ, Limbert C, Docherty A, Barlow J.

Arch Dis Child. 2006 Sep;91(9):740-3. Epub 2006 Mar 23. Review.

26.
27.
28.

Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity.

Michelhaugh SK, Vaitkevicius H, Wang J, Bouhamdan M, Krieg AR, Walker JL, Mendiratta V, Bannon MJ.

J Neurochem. 2005 Dec;95(5):1342-50.

29.

Preferential expression of an AAV-2 construct in NOS-positive interneurons following intrastriatal injection.

Sin M, Walker PD, Bouhamdan M, Quinn JP, Bannon MJ.

Brain Res Mol Brain Res. 2005 Nov 18;141(1):74-82. Epub 2005 Sep 8.

PMID:
16153741
30.

The dopamine transporter: role in neurotoxicity and human disease.

Bannon MJ.

Toxicol Appl Pharmacol. 2005 May 1;204(3):355-60. Review.

PMID:
15845424
31.

Sp1 and Sp3 activate transcription of the human dopamine transporter gene.

Wang J, Bannon MJ.

J Neurochem. 2005 Apr;93(2):474-82.

32.

Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain.

Bouhamdan M, Michelhaugh SK, Calin-Jageman I, Ahern-Djamali S, Bannon MJ.

Biochim Biophys Acta. 2004 May 3;1691(2-3):141-50.

33.

Transcription factors specifying dopamine phenotype are decreased in cocaine users.

Bannon MJ, Pruetz B, Barfield E, Schmidt CJ.

Neuroreport. 2004 Mar 1;15(3):401-4.

PMID:
15094491
34.

Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin.

Albertson DN, Pruetz B, Schmidt CJ, Kuhn DM, Kapatos G, Bannon MJ.

J Neurochem. 2004 Mar;88(5):1211-9.

35.

Paediatricians and child protection: the need for effective education and training.

Bannon MJ, Carter YH.

Arch Dis Child. 2003 Jul;88(7):560-2. No abstract available.

36.

Viewpoint 2--GPs and child protection: time to grasp the nettle.

Carter YH, Bannon MJ.

Br J Gen Pract. 2002 Jun;52(479):514. No abstract available.

37.

Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.

Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6382-5. Epub 2002 Apr 16.

38.

The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons.

Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP.

J Neurochem. 2001 Dec;79(5):1033-8.

39.

The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders.

Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P.

Eur Neuropsychopharmacol. 2001 Dec;11(6):449-55. Review.

PMID:
11704422
40.

Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.

Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ.

J Neurochem. 2001 Mar;76(5):1565-72.

41.

Real-time analysis of preprotachykinin promoter activity in single cortical neurons.

Walker PD, Andrade R, Quinn JP, Bannon MJ.

J Neurochem. 2000 Aug;75(2):882-5.

42.

GP registrars need training in child abuse and neglect.

Bannon MJ, Carter YH, Jackson NR.

Med Educ. 2000 Jan;34(1):77-8. No abstract available.

PMID:
10798927
43.

Characterization of the 5'-flanking region of the human dopamine transporter gene.

Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ.

Brain Res Mol Brain Res. 1999 Dec 10;74(1-2):167-74.

PMID:
10640687
44.
45.

BCG and tuberculosis.

Bannon MJ.

Arch Dis Child. 1999 Jan;80(1):80-3. Review. No abstract available.

46.
47.

Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene.

Granneman JG, Zhai Y, Zhu Z, Bannon MJ, Burchett SA, Schmidt CJ, Andrade R, Cooper J.

Mol Pharmacol. 1998 Oct;54(4):687-94.

PMID:
9765512
48.

Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus.

Hahn MK, Bannon MJ.

Eur J Pharmacol. 1998 May 8;348(2-3):155-60.

PMID:
9652329
49.

Administration of medicines in school: who is responsible?

Bannon MJ, Ross EM.

BMJ. 1998 May 23;316(7144):1591-3. No abstract available.

50.

Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine.

Burchett SA, Volk ML, Bannon MJ, Granneman JG.

J Neurochem. 1998 May;70(5):2216-9.

Supplemental Content

Loading ...
Support Center